Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Diagnostic Medical Systems ( (FR:ALDMS) ) just unveiled an update.
Diagnostic Medical Systems (DMS Group) has published an update on its share capital structure for the end of 2024, indicating a total of 20,852,300 shares and theoretical voting rights numbering 21,923,526, with exercisable rights at 21,101,004. This announcement underscores the company’s transparency and its strategic positioning on the Euronext Growth Paris market, potentially impacting its stakeholders by maintaining confidence in its governance and operational disclosure practices.
More about Diagnostic Medical Systems
DMS Group is a French industrial company specializing in high-performance medical imaging systems, particularly in digital radiology and osteodensitometry. It is internationally oriented, recognized for its quality solutions, flexibility, ingenuity, and responsible values, with 75% of its €42.2 million sales in 2023 being international. The company is listed on the Euronext Growth Paris market and participates in the ETIncelles program for ambitious SMEs.
YTD Price Performance: 2.57%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €13.36M
Learn more about ALDMS stock on TipRanks’ Stock Analysis page.
